Tribal woman files case against Yogi for sharing her nude pic on social media

Mangaluru, Jun 14: A 26-year-old man, who had recently returned to Mangaluru from Maharashtra, succumbed to coronavirus today. With this number of covid-19 deaths in the coastal district of Dakshina Kannada rose to eight.

After returning from Mumbai, he had undergone institutional quarantine on May 28 and 29. Later, he was under home quarantine as he was suffering from kidney related ailment. He completed his home quarantine on June 10.

On June 12, the youth was admitted to the private hospital in the city due to kidney related ailment. He did not respond to treatment and died.

His throat swab sample was tested after which it was confirmed that he was having coronavirus infection also.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Wayanad, April 7: The Kerala government has allowed people from border villages of Karnataka and Tamil Nadu to use medical facilities at Wayanad.

"We have opened our borders to people from neighbouring states who require medical facilities in Kerala. Twenty-nine people from Bairakuppa in Karnataka have used medical facilities in Wayanad and 44 from Tamil Nadu," Kerala Chief Minister Pinarayi Vijayan said on Monday.

Bairakuppa, a small village in Karnataka, is separated by the river Kabini from Wayanad district and the residents there depend on the healthcare facilities available in Wayanad.

Speaking to news agency, Adeela Abdulla, District Collector of Wayanad, said that instructions have been issued to allow people from neighbouring states of Karnataka and Tamil Nadu, who need medical facilities, to cross the border.

"Right from the start of the lockdown, we have not restricted individuals from Bairakuppa region in Mysore district to use the medical facilities in Wayanad as people in that region depend on medical facilities in Wayanad," she said.